Skip to content

PTC Therapeutics PTCT Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
Insmed logo
InsmedINSM

Segments

By segment

See full
Life Science$11.58M+205%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's amortization of capitalized software and acquired intangible assets?
PTC Therapeutics (PTCT) reported amortization of capitalized software and acquired intangible assets of $11.58M in Q1 2026.
How has PTC Therapeutics's amortization of capitalized software and acquired intangible assets changed year-over-year?
PTC Therapeutics's amortization of capitalized software and acquired intangible assets increased by 204.9% year-over-year, from $3.8M to $11.58M.
What is the long-term trend for PTC Therapeutics's amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), PTC Therapeutics's amortization of capitalized software and acquired intangible assets has grown at a -18.0% compound annual growth rate (CAGR), from $54.75M to $24.74M.